RecruitingNot ApplicableNCT06042699

Kids With Iron Deficiency and Scoliosis

Kids With Iron Deficiency and Scoliosis (KIDS) Study


Sponsor

Columbia University

Enrollment

275 participants

Start Date

Jan 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a randomized controlled trial of preoperative oral iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in adolescents undergoing scoliosis surgery. Research Question(s)/Hypothesis(es): Primary * Iron supplementation will reduce the incidence of perioperative RBC transfusion in iron deficient scoliosis patients undergoing spinal fusion. Secondary * Iron supplementation will reduce postoperative neurocognitive functional declines in iron deficient scoliosis patients undergoing spinal fusion. * Iron supplementation will improve patient-reported physical functioning in iron deficient scoliosis patients undergoing spinal fusion.


Eligibility

Min Age: 10 YearsMax Age: 26 Years

Inclusion Criteria5

  • years old;
  • diagnosis of scoliosis or kyphosis;
  • self-reported ability to swallow a tablet;
  • spinal fusion procedure planned approximately 6 to 24 weeks from an orthopedic surgical clinic visit at which patient agrees to phlebotomy for screening blood work;
  • serum ferritin less than or equal to 25 µg/L.

Exclusion Criteria12

  • taking or planning to take iron-containing supplement on patient's own volition, and not willing to stop for duration of study;
  • taking or planning to take iron-containing supplement as prescribed or recommended under the care of a physician;
  • Hg \<10mg/dL if post-menarchal, Hg \< 11 if premenarchal or male
  • C-reactive protein \> 10 mg/L
  • receiving nutritional support by report in the medical chart;
  • self-reported history of hypersensitivity reaction to iron-containing supplements;
  • self-reported history of or suspected non-iron deficient hematologic disorder;
  • self-reported history of iron overloaded state such as hereditary hemochromatosis or hemosiderosis;
  • objection to receiving red blood cell transfusions;
  • current pregnancy (by self-report);
  • prisoners;
  • patient or parent decides against study participation.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTOral ferrous sulfate

Oral ferrous sulfate 325mg is used as a dietary supplement providing 65mg elemental iron.

DIETARY_SUPPLEMENTOral placebo tablet

Oral placebo tablet provided as placebo comparator.


Locations(1)

Columbia University Medical Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06042699


Related Trials